BSE filing, NSE: SHIVACEM. Summary written from the filing by ALFA Finder's alert engine.
Shiva Cement Ltd: key numbers
- Share price
- ₹12.75
- Market cap
- ₹376.1 Cr
- Revenue (annual)
- ₹435.2 Cr
- Net profit (annual)
- ₹-125.5 Cr
- P/E (TTM)
- -3.5×Sector 31.7×
- Promoter holding
- 66.50%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shiva Cement Ltd
All →Shiva Cement Q2 FY27 Results: Net Loss of ₹22.9 Cr, Loss Narrows
Shiva Cement Ltd reported revenue from operations of ₹112.7 Cr (+37.3% YoY) and a net loss of ₹22.9 Cr for Q2 FY27.
- Key figure
- Net loss ₹22.9 Cr
Shiva Cement Board Meeting Date
Shiva Cement Limited has scheduled a board meeting for October 23, 2026. The board will primarily consider and approve unaudited financial results for the quarter ended September 2026.
Shiva Cement Other Announcement
Shiva Cement Ltd submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, received from its RTA for the quarter ended September 30, 2026.
Shiva Cement Acquisition
Shiva Cement Ltd approved a Scheme of Arrangement for its amalgamation into JSW Cement Ltd. Shareholders will receive 5 shares of JSW Cement for every 41 held.
Shiva Cement Capacity Expansion
Shiva Cement expanded its Khatkurbahal (North) mine scope to commercialise 2.4 million tonnes of dolomite annually. The regulatory approval enables a new merchant sales stream in Odisha.
Shiva Cement Q1 FY27 Results: Net Loss of ₹21.3 Cr, Loss Narrows
Shiva Cement Ltd reported revenue from operations of ₹151.5 Cr (+43.5% YoY) and a net loss of ₹21.3 Cr for Q1 FY27.
- Key figure
- Net loss ₹21.3 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.